Press release
Rising Prevalence Of Gastrointestinal Disorders Drives Growth In Gastroretentive Drug Delivery Systems Outsourcing Market: Major Factor in the Transformation of the Gastroretentive Drug Delivery Systems Outsourcing Market in 2025
Gastroretentive Drug Delivery Systems Outsourcing Market Forecast
In recent times, the market size for outsourcing of gastroretentive drug delivery systems has expanded significantly. Projected growth estimates indicate an increase from $1.39 billion in 2024 to $1.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.3%. Several factors have contributed to this growth during the historic period, including a surge in stomach and small intestine ailments, improved drug delivery systems, an escalated prevalence of gastric cancer, amplified government initiatives, and a rise in the number of hospitals.
In the forthcoming years, the gastroretentive drug delivery systems outsourcing market is projected to experience solid growth. By 2029, the market size is anticipated to reach $2.03 billion, at a compound annual growth rate (CAGR) of 7.9%. The market's growth throughout the projected period can be linked to factors such as the rise in ambulatory establishments, increased attention on patient compliance and convenience, the surge in chronic disease prevalence, the growth of personalised medicine, and an expanding senior population. Notable trends during this period encompass advancements in areas like polymer science, the creation of bioadhesive systems, formulation advancements, innovative polymers, drug release modifiers, the evolution of gastroretentive dosage, the incorporation of digital health technologies, intelligent gastroretentive systems, and precise drug delivery.
What Is Stimulating Growth in the Gastroretentive Drug Delivery Systems Outsourcing Market?
The escalating incidences of gastrointestinal disorders is anticipated to stimulate the progress of the gastroretentive drug delivery systems outsourcing market in the future. These disorders refer to a multitude of illnesses affecting the digestive tract, such as the stomach, liver, gallbladder, intestines, and pancreas. The increase in gastrointestinal disorders is due to several reasons including aging populations, usage of antibiotics, infectious agents, changes in diet, stress and lifestyle changes, and obesity. Through outsourcing gastroretentive drug delivery systems, pharmaceutical companies acquire the necessary resources and specialization to tackle the mounting problem of gastrointestinal disorders, ultimately enhancing patient outcomes and quality of life. For example, in January 2023, the American Cancer Society (ACS), a health institution based in the US devoted to the eradication of cancer, reported an increase of 3.18%, equating to 348,840 cases of gastrointestinal cancers, up from 338,090 in 2021 in the United States. Therefore, the escalating incidences of gastrointestinal disorders are propelling the gastroretentive drug delivery systems outsourcing market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp
Who Are the Major Industry Players Fueling Gastroretentive Drug Delivery Systems Outsourcing Market Expansion?
Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc., Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.
Which Key Developments Are Influencing the Gastroretentive Drug Delivery Systems Outsourcing Market?
Leading firms in the gastroretentive drug delivery systems outsourcing market are concentrating on the creation of innovative products like ready-to-fill (RTF) colon functional capsules. These aim to improve the efficiency of drug delivery and patient comfort. These ready-to-fill (RTF) colon functional capsules are pre-manufactured, hollow capsules designed to be filled with specific formulas or active components for the colon. For example, in September 2024, Germany-based Evonik, a pioneer in advanced drug delivery, introduced its EUDRACAP colon functional capsules. These are engineered for the targeted delivery of oral drugs towards the ileo-colonic area. These groundbreaking capsules are the pioneer ready-to-fill solution in the market and are designed to deliver sensitive active components like live biotherapeutic products (LBPs). Presently, they are available in technical grade, with a GMP-grade product also being developed. EUDRACAP colon simplifies the formulation and accelerates the market release of oral drugs, representing a significant breakthrough in gastroretentive drug delivery systems.
How Is the Segmentation of the Gastroretentive Drug Delivery Systems Outsourcing Market Defined?
The gastroretentive drug delivery systems outsourcing market covered in this report is segmented -
1) By Type: Floating Systems, Bioadhesive Systems, Other Types
2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users
Subsegments:
1) Floating Systems: Single Unit Systems, Multiple Unit Systems
2) Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers
3) Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report
What Is the Leading Region in the Gastroretentive Drug Delivery Systems Outsourcing Market?
North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Gastroretentive Drug Delivery Systems Outsourcing Global Market Report?
- Market Size Analysis: Analyze the Gastroretentive Drug Delivery Systems Outsourcing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Gastroretentive Drug Delivery Systems Outsourcing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Gastroretentive Drug Delivery Systems Outsourcing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Gastroretentive Drug Delivery Systems Outsourcing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15813
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Gastrointestinal Disorders Drives Growth In Gastroretentive Drug Delivery Systems Outsourcing Market: Major Factor in the Transformation of the Gastroretentive Drug Delivery Systems Outsourcing Market in 2025 here
News-ID: 3862311 • Views: …
More Releases from The Business Research Company
C-X-C Chemokine Receptor Type 2 Market on Track for Strong Growth, Estimated to …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the C-X-C Chemokine Receptor Type 2 Market Through 2025?
There has been a significant expansion in the market for C-X-C chemokine receptor type 2 in the past few years. The market is projected to increase from $1.24 billion in 2024 to $1.38 billion…
Top Market Shifts Transforming the Coenzyme Q10 Market Landscape: Key Insights
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Coenzyme Q10 Market Through 2025?
The market size of coenzyme Q10 has seen impressive expansion in the past years, with predictions stating an increase from $0.74 billion in 2024 up to $0.84 billion in 2025, implying a compound annual growth rate (CAGR)…
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chimeric Antibody Market Through 2025?
In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)…
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chimeric Antibody Market Through 2025?
In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)…
More Releases for Delivery
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Last Mile Delivery: Your Fast Track to Delivery Efficiency
The importance of last-mile logistics has increased significantly in recent years due to the rapid growth of e-commerce, evolving consumer demands, and the necessity for efficient and timely deliveries. Covid-19 has also played a part in hastening the rise of last-mile deliveries. In logistics, 'first-mile' and 'last-mile' delivery are terms used to describe the movement of goods within the supply chain. The first leg of the supply chain journey commences…
Smart Drug Delivery Systems Market: Revolutionizing Healthcare Delivery
In a rapidly evolving landscape of healthcare, smart drug delivery systems (SDDS) have emerged as a transformative force, catering to the increasing demand for advanced treatment solutions. According to a recent report, the global smart drug delivery systems market was valued at a staggering US$ 8.7 billion in 2022, with projections indicating a remarkable CAGR of 15.2% from 2022 to 2031. By the end of this forecast period, the market…
Revolutionizing Last-Mile Delivery: The Growing Delivery Robots Market
"According to the research report, the global delivery robots market was valued at USD 148.07 million in 2022 and is expected to reach USD 2,148.92 million by 2032, to grow at a CAGR of 30.7% during the forecast period."
Polaris Market Research has recently published the latest update on Delivery Robots Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2030 that offers detailed market analysis, encompassing its…
Nasal Drug Delivery Market - Effortless Delivery, Optimal Results: Nasal Drug De …
Newark, New Castle, USA - new report, titled Nasal Drug Delivery Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Nasal Drug Delivery market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Nasal Drug Delivery market. The report offers an overview of…
Telemedicine Market Report 2022 by Mode of Delivery, End User, Region-Cloud base …
The Telemedicine market will reach US$ 387.7 Mn by 2028 - Persistence Market Research (PMR), a well-known name in market research.
The current scenario is such that people and healthcare professionals are increasingly preferring virtual consulting due its low costs and effective treatment. This scenario is, by all means, favoring the Telemedicine market growth.
The forecast period (2022-2028) will see North America scale greater heights in the Telemedicine market. This is basically…
